Search Within

Andrew D Seidman

  1. "Mark Robson"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (12)
Groups
  1. Breast Medicine Service (26)
  2. Department of Medicine (26)
  3. Population Sciences Research Program (26)
  4. Solid Tumor Oncology Division (26)
  5. Survivorship Research (26)
  6. Epidemiology and Biostatistics (22)

More Groups

People
  1. Mark Robson (26)
  2. Chau Dang (17)
  3. Clifford Hudis (14)
  4. Gabriella D'Andrea-Carlino (13)
  5. Larry Norton (13)
  6. Monica Fornier (13)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (1)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Breast Cancer Research and Treatment (4)
  3. Clinical Cancer Research (3)
  4. Cancer Research (2)
  5. European Journal of Cancer (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (5)
  3. Elsevier Inc. (4)
  4. Springer (4)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    Journal Article

    Hurria, A.; Zuckerman, E.; Panageas, K. S.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Journal of the American Geriatrics Society (2006)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of adjuvant chemotherapy for breast cancer (BC) on older patients' functional status and quality of life
    Meeting Abstract

    Hurria, A.; Panageas, K.; Zuckerman, E.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Increased dose-density (DD) is feasible: A pilot study of epirubicin and cyclophosphamide (EC) followed by paclitaxel (T), at 10-11 day interval with filgrastim support, for women with early breast carcinoma (BC)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C. H.; Panageas, K.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer
    Journal Article

    Dang, C. T.; D'Andrea, G. M.; Moynahan, M. E.; Dickler, M. N.; Seidman, A. D.; Fornier, M.; Robson, M. E.; Theodoulou, M.; Lake, D.; Currie, V. E.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save